Literature DB >> 12686659

Iron-mobilizing properties of the gadolinium-DTPA complex: clinical and experimental observations.

Marina Vorobiov1, Anna Basok, David Tovbin, Alla Shnaider, Leonid Katchko, Boris Rogachev.   

Abstract

BACKGROUND: Gadolinium (Gd) magnetic resonance imaging (MRI) contrast agents are considered to be safe in patients with impaired renal function. Our study investigates a mechanism of severe iron intoxication with life-threatening serum iron levels in a haemodialysis patient following MRI with Gd-diethylenetriaminepentaacetic acid (Gd-DTPA) administration. His previous history was remarkable for multiple blood transfusions and biochemical evidence of iron overload. We hypothesized that Gd-DTPA may have an iron-mobilizing effect in specific conditions of iron overload combined with prolonged exposure to the agent.
METHODS: For the in vitro study, Gd-DTPA was added to mice liver homogenate and iron metabolism parameters were measured after incubation in comparison with the same samples incubated with saline only. For the in vivo study, an experimental model of acute renal failure in iron-overloaded rats was designed. Previously iron-overloaded and normally fed rats underwent bilateral nephrectomy by renal pedicle ligation, followed by Gd-DTPA or saline injection. Iron and iron saturation levels were checked before and 24 h after Gd-DTPA or vehicle administration.
RESULTS: Significant mobilization of iron from mice liver tissue homogenate in mixtures with Gd in vitro was seen in the control (saline) and in the experimental (Gd) groups (513+/-99.1 vs 1117.8+/-360.8 microg/dl, respectively; P<0.05). Administration of Gd-DTPA to iron-overloaded rats after renal pedicle ligation caused marked elevation of serum iron from baseline 143+/-3.4 to 570+/-8 microg/dl (P<0.0001). There were no changes of the named parameter, either in iron-overloaded anuric rats after saline injection or in normal diet uraemic animals, following Gd-DTPA administration.
CONCLUSIONS: The combination of iron overload and lack of adequate clearance of Gd chelates may cause massive liberation of iron with dangerous elevation of free serum iron. It is highly recommended that after Gd contrast study, end-stage renal disease patients with probable iron overload should undergo prompt and intensive haemodialysis for prevention of this serious complication.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686659     DOI: 10.1093/ndt/gfg064

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 2.  Gadolinium-based contrast agents: did we miss something in the last 25 years?

Authors:  Bruno Beomonte Zobel; Carlo Cosimo Quattrocchi; Yuri Errante; Rosario Francesco Grasso
Journal:  Radiol Med       Date:  2015-12-26       Impact factor: 3.469

3.  Trace element analysis of human urine collected after administration of Gd-based MRI contrast agents: characterizing spectral interferences using inorganic mass spectrometry.

Authors:  Amy J Steuerwald; Patrick J Parsons; John G Arnason; Zhen Chen; C Matthew Peterson; Germaine M Buck Louis
Journal:  J Anal At Spectrom       Date:  2013-06       Impact factor: 4.023

4.  Myelin imaging compound (MIC) enhanced magnetic resonance imaging of myelination.

Authors:  Luca Frullano; Junqing Zhu; Changning Wang; Chunying Wu; Robert H Miller; Yanming Wang
Journal:  J Med Chem       Date:  2011-12-16       Impact factor: 7.446

Review 5.  Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity.

Authors:  Derrick J Todd; Jonathan Kay
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

6.  Stability of MRI contrast agents in high-energy radiation of a 1.5T MR-Linac.

Authors:  Jihong Wang; Travis Salzillo; Yongying Jiang; Yuri Mackeyev; Clifton David Fuller; Caroline Chung; Seungtaek Choi; Neil Hughes; Yao Ding; Jinzhong Yang; Sastry Vedam; Sunil Krishnan
Journal:  Radiother Oncol       Date:  2021-06-03       Impact factor: 6.901

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.